[
    [
        {
            "time": "2023-04-16",
            "original_text": "凯莱英：1018万股限售股4月16日解禁，其中高瓴资本持有440.5万股 解禁",
            "features": {
                "keywords": [
                    "凯莱英",
                    "限售股",
                    "解禁",
                    "高瓴资本"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英：1018万股限售股4月16日解禁，其中高瓴资本持有440.5万股 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-16",
            "original_text": "凯莱英(002821.SZ)：1017.87万股限售股将于4月16日上市流通 解禁",
            "features": {
                "keywords": [
                    "凯莱英",
                    "限售股",
                    "解禁",
                    "上市流通"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)：1017.87万股限售股将于4月16日上市流通 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-16",
            "original_text": "凯莱英：1017.8万股限售股4月16日解禁，高瓴资本持股440.5万股 解禁",
            "features": {
                "keywords": [
                    "凯莱英",
                    "限售股",
                    "解禁",
                    "高瓴资本"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英：1017.8万股限售股4月16日解禁，高瓴资本持股440.5万股 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-16",
            "original_text": "高瓴资本概念股普遍强势，金域、健帆、甘李、凯莱英、广联达纷纷走升",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "强势",
                    "凯莱英",
                    "金域",
                    "健帆",
                    "甘李",
                    "广联达"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍强势，金域、健帆、甘李、凯莱英、广联达纷纷走升",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]